PL353057A1 - Sposób zapobiegania wzrostowi nowotworu - Google Patents

Sposób zapobiegania wzrostowi nowotworu

Info

Publication number
PL353057A1
PL353057A1 PL00353057A PL35305700A PL353057A1 PL 353057 A1 PL353057 A1 PL 353057A1 PL 00353057 A PL00353057 A PL 00353057A PL 35305700 A PL35305700 A PL 35305700A PL 353057 A1 PL353057 A1 PL 353057A1
Authority
PL
Poland
Prior art keywords
tumoral growth
preventing
growth
preventing tumoral
ltbr
Prior art date
Application number
PL00353057A
Other languages
English (en)
Inventor
Daniela N. Mannel
Thomas Hehlgans
Carola Seitz
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999129488 external-priority patent/DE19929488A1/de
Priority claimed from DE2000104447 external-priority patent/DE10004447A1/de
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of PL353057A1 publication Critical patent/PL353057A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C07K14/5255—Lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
PL00353057A 1999-06-28 2000-06-21 Sposób zapobiegania wzrostowi nowotworu PL353057A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1999129488 DE19929488A1 (de) 1999-06-28 1999-06-28 Verfahren zur Verhinderung von Tumorwachstum
DE2000104447 DE10004447A1 (de) 2000-02-03 2000-02-03 Verfahren zur Verhinderung von Tumorwachstum

Publications (1)

Publication Number Publication Date
PL353057A1 true PL353057A1 (pl) 2003-10-06

Family

ID=26004148

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353057A PL353057A1 (pl) 1999-06-28 2000-06-21 Sposób zapobiegania wzrostowi nowotworu

Country Status (20)

Country Link
EP (1) EP1189626B1 (pl)
JP (1) JP3822822B2 (pl)
KR (1) KR20020016852A (pl)
CN (1) CN1359297A (pl)
AT (1) ATE410180T1 (pl)
AU (1) AU5406000A (pl)
BG (1) BG106246A (pl)
BR (1) BR0012006A (pl)
CA (1) CA2376920A1 (pl)
DE (1) DE50015391D1 (pl)
ES (1) ES2313893T3 (pl)
HK (1) HK1047045A1 (pl)
HU (1) HUP0201804A2 (pl)
IL (1) IL147180A0 (pl)
MX (1) MXPA01013367A (pl)
NO (1) NO20016380L (pl)
PL (1) PL353057A1 (pl)
SK (1) SK18852001A3 (pl)
TR (1) TR200103841T2 (pl)
WO (1) WO2001000228A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL134994A0 (en) 2000-03-09 2001-05-20 Yeda Res & Dev Coupled two way clustering analysis of data
EP1577323B1 (en) 2002-12-26 2013-07-10 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
AR049938A1 (es) 2004-06-25 2006-09-13 Takeda Pharmaceutical Derivados de metastina y utilizacion de los mismos
WO2007041694A2 (en) * 2005-10-04 2007-04-12 The Johns Hopkins University Compositions and methods for treating inflammation
AR058584A1 (es) 2005-12-22 2008-02-13 Takeda Pharmaceutical Derivados de metastina y uso de los mismos
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JO3048B1 (ar) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co مشتقات متاستين واستخدامها
US8440185B2 (en) 2006-12-26 2013-05-14 The Johns Hopkins University Compositions and methods for the treatment of immunologic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925351A (en) * 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
ATE331531T1 (de) * 1996-10-25 2006-07-15 Biogen Idec Inc Lösliche lymphotoxin-beta rezeptoren, anti- lymphotoxin-antikörper und anti-lymphotoxin ligand antikörper als therapeutische wirkstoffe zur behandlung von immunologischen krankheiten
IL137489A0 (en) * 1998-01-30 2001-07-24 Univ New York Pharmaceutical compositions containing inhibitors of the lymphotoxin pathway

Also Published As

Publication number Publication date
EP1189626A1 (de) 2002-03-27
MXPA01013367A (es) 2002-07-02
BG106246A (bg) 2002-10-31
ES2313893T3 (es) 2009-03-16
AU5406000A (en) 2001-01-31
IL147180A0 (en) 2002-08-14
KR20020016852A (ko) 2002-03-06
TR200103841T2 (tr) 2002-06-21
SK18852001A3 (sk) 2002-12-03
ATE410180T1 (de) 2008-10-15
HK1047045A1 (zh) 2003-02-07
HUP0201804A2 (en) 2002-09-28
JP2003503359A (ja) 2003-01-28
NO20016380D0 (no) 2001-12-27
CA2376920A1 (en) 2001-01-04
JP3822822B2 (ja) 2006-09-20
EP1189626B1 (de) 2008-10-08
CN1359297A (zh) 2002-07-17
WO2001000228A1 (de) 2001-01-04
DE50015391D1 (de) 2008-11-20
NO20016380L (no) 2001-12-27
BR0012006A (pt) 2002-03-12

Similar Documents

Publication Publication Date Title
USD444407S1 (en) Necklace
USD490438S1 (en) Graphical display for a binaural hearing aid
USD466701S1 (en) Tanned hide
IL250619B (en) Substrate without proteins and without serum for cell cultivation
BG107317A (en) Transcutaneous prosthesis
ATE302040T1 (de) Ringstent
AU2430601A (en) Ion implantation ion source, system and method
AU2002214646A1 (en) System, method, and article of manufacture for locating and communicating with apatron at a hospitality facility
IL147803A0 (en) 28-epirapalogs
AU5784600A (en) A system, method and article of manufacture for software source authentication for return purposes
USD482057S1 (en) Animal type font
AU6744000A (en) A light source, and a field emission cathode
DE50213926D1 (de) Portsystem für einen perkutan implantierten port
AU2002221908A1 (en) Novel use of protein hydrolysates
IL147180A0 (en) Method for preventing tumoral growth
USD427416S (en) Rawhide treat
AU2001264769A1 (en) Induction of apoptosis and cell growth inhibition by protein 4.33
USD452958S1 (en) Necklace
USD413813S (en) Decorative clock
EP0943311A3 (en) Method of inhibiting hair growth
IL154776A0 (en) Method for the preparation of 21-hydroxy-6, 19-oxidoprogesterone and derivatives thereof
LT2002096A (en) Dental implant-carrier assembly
EP1081868A3 (en) Supporting an E2PRML-type channel and an EPRML-type channel with the same trellis structure
AU4505501A (en) A computer implemented method of implementing, maintaining, and updating a brandarchitecture system
AU6724500A (en) Motorcyclist suit